IL26 and bacterial pneumonia: Taken together, our findings demonstrate that IL-26 is involved in the innate immune response during bacterial pneumonia in humans, that this cytokine may both enhance and limit this immune response, and that endogenous IL-26 triggered by a Gram-negative bacterial species contributes to the killing of the same bacteria.